Sarah Rahal’s most instructive business decision was not a launch. It was a delay. Retailers had begun calling, offering the delicious proof every founder wants: a buyer, a shelf, a shortcut into ordinary life. Rahal declined for more than a year. ARMRA, the company she founded around bovine colostrum, had started online with one flagship product and a long explanation attached. She was not yet willing to squeeze that explanation into the few seconds a shopper grants a jar in an aisle.
The refusal becomes more striking when set beside what followed. ARMRA launched direct-to-consumer in 2020. By late spring 2026, the company reported more than 7,600 retail doors across chains including Whole Foods Market, Walmart, Sprouts, Target, Ulta Beauty, H-E-B and The Vitamin Shoppe. By September, Rahal said the full portfolio had reached 10,000 doors. Six years took the company from a single unfamiliar product to national distribution. One of those years was spent making sure growth would not arrive before comprehension.
“Distribution is not velocity,” Rahal has said. It is a lean little sentence with the efficiency of a clinical note. A retailer can place something on a shelf. It cannot make anyone understand it, want it, finish it or buy it twice. The distinction is the center of her operating philosophy: access matters, but repetition is proof.
Three careers, one recurring job
Rahal’s route to the consumer shelf began with physics. She graduated magna cum laude from Georgetown University in 2005, then earned her medical degree from New York Medical College four years later. Pediatrics training at Westchester Medical Center led to a child-neurology residency at Columbia, followed by a headache-medicine fellowship at Mount Sinai. By 2015 she was an assistant professor of neurology and pediatrics at the Icahn School of Medicine at Mount Sinai, where she also directed pediatric headache care.
Read as a résumé, the progression looks linear: science, medicine, specialization, faculty. Read as preparation for entrepreneurship, it contains a less obvious apprenticeship. Physics asks what remains true when assumptions are stripped away. Medicine trains attention. A specialist must also translate: years of technical knowledge must become language another person can use. That skill would prove useful when Rahal left a profession whose vocabulary was established to enter a market whose central noun still needed an introduction.
She has described an important correction to her own self-image. Before ARMRA, Rahal thought of herself as risk-averse. She had never done anything except medicine. Building a company showed her that the more durable identity was simpler: “I’m just a problem solver.” There is both modesty and nerve in that phrase. It shrinks a dramatic career change into a familiar task, then quietly expands the territory where the task may be attempted.
“Don’t believe everything you think about yourself.”Sarah Rahal on the surprise of becoming a founder
Before preference comes recognition
In 2019, Rahal founded Rahal Biosciences and became ARMRA’s chief executive. She then spent a reported two years developing the company’s proprietary low-temperature processing method. The first ARMRA packaging entered commercial use on June 10, 2020, according to Rahal’s later trademark declaration. The launch offered one concentrated powder and an educational problem disguised as a branding problem.
Colostrum was neither a newly invented ingredient nor an established American pantry category. ARMRA therefore had to do two jobs in the correct order. It had to explain what the thing was before arguing why its version should be chosen. Direct-to-consumer commerce, with its generous pages, email sequences, interviews and founder-led storytelling, provided room. A store shelf offered inches.
This is why waiting mattered. A young brand can mistake availability for arrival. Rahal wanted the language to be sturdy enough to survive outside the company’s own website. When ARMRA did enter national retail, it carried not only packaging but years of practiced explanation and a community capable of repeating the story in its own words.
Rahal describes those customers less as an audience than as collaborators. Early on, she was the narrator, supplying vocabulary. Over time, people described how the product fitted their routines and gave the category “their own voice.” The company listened. Its newest format, a ready-to-drink soda, grew from customer requests and took two years to develop. An unusual ingredient moved into a familiar can. The translation became physical.
From a product page to the aisle
Retail-door figures are company-reported. The 2020 marker represents the single-product direct-to-consumer launch, not a door count.
Curiosity gets a vote. Habit decides.
The soda is Rahal’s current test of her own maxim. It is brightly packaged, priced like a premium functional drink and strange enough to earn a first glance. None of that guarantees a second purchase. When asked what metric matters, Rahal was precise: “Trial only tells you the idea was interesting. Reorders tell you it’s in the routine.” Curiosity can produce a launch photo. Habit produces a category.
That answer resists a familiar founder temptation. Novelty is wonderfully easy to photograph and notoriously hard to live on. A new format can broaden an occasion, but the customer must still decide that the item belongs in the refrigerator again. Rahal has said a real colostrum-drink category will exist when retailers create a shelf set for it, shoppers no longer require the ingredient explained, and repeat purchase carries the business. By her own definition, the experiment remains open.
The wider expansion is no longer tentative. In 2026, Inc. placed Rahal on its Female Founders 500, recognizing the national retail push. ARMRA’s reported late-spring footprint was more than eight times its size a year earlier. The company also moved across formats and contexts: beauty at Ulta, performance at the Miami Open, groceries at Whole Foods, mass retail at Walmart, and a can intended for a cold case rather than a supplement shelf.
This is omnichannel growth, but Rahal speaks about it as a sequence of different listeners. Every setting introduces “different kinds of ears,” she says. The phrase reveals an educator’s instinct. A category does not scale merely because the same message is repeated more loudly. It scales when the explanation changes shape without changing meaning.
“They give it their own voice, and then together we get louder.”Sarah Rahal on customers and category-building
A shelf leaves no room for footnotes
Rahal’s earlier work trained her for rooms in which attention could be earned slowly. A consultation permits questions. A lecture can define its terms. A long interview can wander, return and clarify. Retail is less courteous. The shopper is moving, competing labels are close enough to touch, and the package must answer several questions before the cart rolls on. What is this? Why is it here? Why this one? The migration from online commerce to stores was therefore not simply a distribution project. It was an editing project.
ARMRA’s expansion across different retailers made the edit harder. A beauty shopper at Ulta approaches the shelf with a different frame from a grocery shopper at Whole Foods or a performance-minded customer at The Vitamin Shoppe. The product does not change identity at every doorway, but the first sentence may have to. Rahal’s phrase “different kinds of ears” turns segmentation into something less mechanical: before speaking, notice who is listening and what they already know.
The Miami Open offered a vivid version of that exercise. ARMRA occupied a suite amid sunscreen, sportswear and the easy theater of a tournament crowd. The setting connected a packaged powder to an occasion without requiring a pharmacy-like environment. Rahal sat for an interview there in 2025, extending the same founder-led explanation that had powered the company online. The venue changed; the habit of teaching did not.
A year later, the reported door count made the company look suddenly ubiquitous. Yet ubiquity is only the visible layer. Beneath it sat the slower accumulation of packaging decisions, retail partnerships, interviews, customer vocabulary and repeated demonstrations. Rahal’s restraint had not delayed the work. It had moved the work upstream, to the place where meaning could still be adjusted before thousands of shelves fixed it in public.
The palindrome was a clue
ARMRA is a palindrome and a play on “armor.” The name was meant to suggest symmetry and balance. It also looks the same from either direction, a useful emblem for Rahal’s career. From physician to founder is the obvious reading. In reverse, the company reveals how much of the physician remained: the appetite for research, the insistence on standards, the compulsion to make a complicated system understandable.
She has called ARMRA her life’s work and said she wants it in every household. That ambition is not shy. Yet the path has been defined by selective movement: one launch product, two years on a process, more than a year of declined retail approaches, two years on a drink. The scale is national; the cadence is patient.
“You can write your own playbook,” Rahal once offered as advice. Hers now contains an appealing contradiction. Build the category, but do not hurry the aisle. Welcome attention, but measure the return. Teach people the words, then listen when they speak them differently. The founder can begin the sentence. If the work is going well, customers will finish it.